Prof. Dingwei Ye

Fudan University Cancer Hospital, China

Email: dwyeli@yahoo.com.cn

Qualifications

1993 M.Sc., Second Military Medical University, China

1992 B.Sc., Shanghai Institute of Oncology, China

Publications (Selected)

1. CaoDL, YaoXD, YeDW,et alA multiplex model of combining gene-based, protein- based and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer. Prostate, e-pub ahead of print 18 October 2010, DOI: 10.1002/pros.21286
2. Zhang HL, Yang LF, Zhu Y,et al. SerummiRNA-21:Elevated Levels in Patients With Metastatic Hormone-Refractory Prostate Cancer and Potential Predictive Factor for the Efficacy of Docetaxel-Based Chemotherapy. Prostate, e-pub ahead of print 18 October 2010
3. Qin XJ，YeDW，et al. Re: Jutta Engel, Patrick J. Bastian, Helmut Baur, et al. Survival Benefit of Radical Prostatectomy in Lymph Node–Positive Patients with Prostate Cancer. Eur Urol 2010,58(4), e43
4. Shi GH，YeDW，YaoXD，et al. Involvement of microRNA-21 inmediating chemoresistance to docetaxel in androgenindependentprostate cancer PC3 cells, APS,2010,31(7):867-873.
5. Zhu YP，Ye DW. Re: Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease. Clin Chim Acta,2010,41(23):2117.
6. Qin XJ, Ma CG, Ye DW, et al. Tumor cytoreduction results in better response to androgen ablation- a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer. Urologic Oncology: Seminars and Original Investigations.2010 May 5. [Epub ahead of print]
7. Dai B, Kong YY, Ye DW, Ma CG, Zhou X,YaoXD. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics. BJU Int. 2009, 104(7): 1009-1016.
8. Zhu YP, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ, Zhu Y, Shi GH.Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries.Asian J Androl. 2009 Jan;11(1):104-8.
9. Lin GW, Yao XD, Zhang SL, Dai B, Ma CG, Zhang HL, Shen YJ, Zhu Y, Zhu YP, Shi GH, Qin XJ, Ye DW.Prostate-specific antigen half-life: a new predictor of progression -free survival and overall survival in Chinese prostate cancer patients.Asian J Androl. 2009 Feb 2
10. Dai B, Kong YY, Ye DW, Ma CG，Zhou XY, Yao XD. HER2 protein expression in Chinese metastatic prostate cancer patients correlates with cancer specific survival and increases after exposure to hormonal therapy.Asian J Androl. 2008 Sep; 10(5): 701-9
11. Dai B, Ye DW, Kong YY, Shen YJ, Wang BH.Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels.Asian J Androl. 2008 Mar;10(2):325-31.
12. Zhang HL,Ye DW, et al.Docetaxel plus Prednisone Versus Mitoxantrone plus Prednisone for Metastatic Hormone-Refractory Prostate Cancer in Chinese Patients: Experience of a Single Center.Urologia Internationalis 2007,79:307-311
13. Ye DW, Mendelsohn J, Fan Z. Augmentation of a humanized anti-HER mAb2 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225. Oncogene 1999;18:731
14. Ye DW, Mendelsohn J, Fan Z. Androgen and EGF downregulate cyclin-dependent kinase inhibitor p27kip1 and co-stimulate proliferation in two newly established prostatic cancer cell lines,MDA Pca2aand MDA Pca 2b.  Clin Cancer Res, 1999, 5:2171-2177.
15. Zhu Y, Zhang SL, Ye DW, et al. Feasibility and activity of sorafenib and sunitinib in advanced penile cancer: a preliminary report. Urol Int,2010,85(3):334-340.
16. Zhu Y, Zhang SL, Ye DW,et al.  Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes. J Urol,2010,184(2):539-545.
17. Zhu Y, Zhang SL, Ye DW, et al. Repeat dynamic sentinel node biopsy in locally recurrent penile carcinoma. BJU Int.2010, 105(12):1732
18. Shi GH, YeDW, YaoXD, et al. Extramammary Paget’s diseases in men from theShanghai area: its association with PSA level increase. APMIS, 2010, 118(10): 777-781.
19. Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ.The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.J Urol.2008 Nov;180(5):2019-23.
20. Zhu Y , Zhou XY,YaoXD, Dai B, Ye DW. The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 inpenile squamous cell carcinoma treated with surgery. BJU Int. 2007 Jul;100(1):204-8.
21. Zhu Y, Ye DW, Chen ZW, Zhang SL, Qin XJ. Frozen section-guided wide local excision in the treatment of penoscrotal extramammary Pagets disease.  BJU Int. 2007 Dec;100(6):1282-7.
22. Zhu Y, Zhang SL, Ye DW,YaoXD, Jiang ZX, Zhou XY. Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquets node, and disease burden of inguinal lymph nodes. Onkologie. 2008 Feb;31(1-2):37-41.
23. Dai B, Ye DW, Kong YY,YaoXD, Zhang HL, Shen YJ. Predicting Regional Lymph Node Metastasis in Chinese Patients With Penile Squamous Cell Carcinoma: The Role of Histopathological classification, Tumor Stage and Depth of Invasion. J Urol. 2006 Oct;176(4 Pt1):1431-5.
24. Zhang HL, Ye DW，et al. Role of KIT Expression in the Prognosis of Clear Cell Renal Cell Carcinomas in Chinese Patients. Journal of cancer research and clinical oncology.2009.
25. Zhang HL, Dong BJ, Lu JJ, Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: results from a multicenter study. BMC Cancer. 2009 Jul 21;9:249.